Bruker Corporation
BRKR
$72.52
$2.483.53%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 841.40M | 742.80M | 681.90M | 682.60M | 702.20M |
| Total Other Revenue | 13.10M | -- | -- | 2.70M | 6.20M |
| Total Revenue | 854.50M | 742.80M | 681.90M | 685.30M | 708.40M |
| Cost of Revenue | 420.10M | 358.90M | 340.90M | 325.30M | 342.70M |
| Gross Profit | 434.40M | 383.90M | 341.00M | 360.00M | 365.70M |
| SG&A Expenses | 206.90M | 178.50M | 179.10M | 162.80M | 164.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 6.80M | 3.20M | 1.00M | 2.10M | 1.70M |
| Total Operating Expenses | 717.30M | 611.90M | 592.00M | 559.20M | 572.50M |
| Operating Income | 137.20M | 130.90M | 89.90M | 126.10M | 135.90M |
| Income Before Tax | 241.70M | 119.50M | 77.70M | 107.30M | 121.70M |
| Income Tax Expenses | 37.10M | 30.80M | 19.90M | 29.90M | 23.40M |
| Earnings from Continuing Operations | 204.60M | 88.70M | 57.80M | 77.40M | 98.30M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 900.00K | -600.00K | -700.00K | -900.00K | -900.00K |
| Net Income | 205.50M | 88.10M | 57.10M | 76.50M | 97.40M |
| EBIT | 137.20M | 130.90M | 89.90M | 126.10M | 135.90M |
| EBITDA | 174.50M | 157.50M | 115.80M | 151.20M | 160.40M |
| EPS Basic | 1.41 | 0.60 | 0.39 | 0.52 | 0.66 |
| Normalized Basic EPS | 0.62 | 0.53 | 0.39 | 0.50 | 0.53 |
| EPS Diluted | 1.41 | 0.60 | 0.39 | 0.52 | 0.66 |
| Normalized Diluted EPS | 0.62 | 0.53 | 0.39 | 0.49 | 0.53 |
| Average Basic Shares Outstanding | 145.50M | 146.60M | 146.80M | 146.80M | 147.10M |
| Average Diluted Shares Outstanding | 146.00M | 147.30M | 147.70M | 147.60M | 147.90M |
| Dividend Per Share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Payout Ratio | 3.55% | 8.40% | 12.78% | 9.67% | 7.60% |
